Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P67
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q1 2026 | -3.09% |
| Q4 2025 | -9.42% |
| Q3 2025 | 2.52% |
| Q2 2025 | -10.83% |
| Q1 2025 | -12.34% |
| Q4 2024 | -8.27% |
| Q3 2024 | -8.77% |
| Q2 2024 | -5.74% |
| Q1 2024 | -0.17% |
| Q4 2023 | -5.27% |
| Q3 2023 | -5.26% |
| Q2 2023 | -3.74% |
| Q1 2023 | -5.07% |
| Q4 2022 | -9.67% |
| Q3 2022 | -2.56% |
| Q2 2022 | -5.61% |
| Q1 2022 | -4.64% |
| Q4 2021 | -1.71% |
| Q3 2021 | -8.91% |
| Q2 2021 | 148.69% |
| Q1 2021 | 58.25% |
| Q4 2020 | -6.52% |
| Q3 2020 | 54.12% |
| Q2 2020 | -5.57% |
| Q1 2020 | 1.54% |
| Q4 2019 | -11.49% |
| Q3 2019 | -14.47% |
| Q2 2019 | 17.06% |
| Q1 2019 | -3.08% |
| Q4 2018 | -17.23% |
| Q3 2018 | -7.16% |
| Q2 2018 | -6.56% |
| Q1 2018 | -19.17% |
| Q4 2017 | 26.56% |
| Q3 2017 | 2.20% |
| Q2 2017 | 184.54% |
| Q1 2017 | -524.89% |
| Q4 2016 | -47.75% |
| Q3 2016 | -34.92% |
| Q2 2016 | -19.39% |